| | | | | | | | | | |
| |
|
|
| Dockets Entered
On July 14, 2005
Table of Contents
|
|
|
|
|
|
|
| |
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1977N-0318
|
| Penicillin & Tetracycline and all Combinations
|
| |
|
|
| 1991V-0204
|
| Laser Light Show
|
| |
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
| |
|
|
| 2002E-0065
|
| Patent Term Application for Kineret No. 5,075,222
|
| |
|
|
| 2002E-0344
|
| Patent Term Application for ATS Open Pivot Bileaf Valve 5,35
|
| |
|
|
| 2003E-0033
|
| Patent Extension Application for DERMAGRAFT No. 4,963,489
|
| |
|
|
| 2003E-0410
|
| Patent Term Restoration Application for Zubrin (tepoxalin), U.S. Patent No. 4,826,868
|
| |
|
|
| 2003P-0176
|
| Follow-Up Approval of Therapeutic Protein Products
|
| |
|
|
| 2004E-0402
|
| Patent Extension for AVASTIN (bevacizumab), U.S. Patent No. 6,054,297
|
| |
|
|
| 2004P-0171
|
| Standards for 'Similarity' or 'Sameness' of Biotechnology-Derived Products
|
| |
|
|
| 2004V-0537
|
| Projector for a Laser Light Show
|
| |
|
|
| 2005D-0122
|
| Guidance for Industry on Exploratory IND Studies
|
| |
|
|
| 2005E-0233
|
| Patent Extension for OMACOR (EPA ethyl ester and DHA ethyl ester), U.S. Patent No. 5,502,077
|
| |
|
|
| 2005E-0234
|
| Patent Extension Application for Macugen (pegaptanib sodium), U.S. Patent No. 6,051,698
|
| |
|
|
| 2005E-0235
|
| Patent Extension Application for VESIcare (solifenacin succinate), U.S. Patent No. 6,017,927
|
| |
|
|
| 2005E-0236
|
| Patent Extension Application for MULTIHANCE (gadobenate dimeglumine), U.S. Patent No. 4,912,246
|
| |
|
|
| 2005E-0238
|
| Patent Extension Application for TYSABRI (natalizumab), U.S. Patent No. 5,840,299
|
| |
|
|
| 2005E-0239
|
| Patent Extension Application for PRIALT (ziconotide), U.S. Patent No. 5,364,842
|
| |
|
|
| 2005E-0246
|
| Patent Extension Appliation for PRIALT (ziconotide), U.S. Patent No. 5,795,864
|
| |
|
|
| 2005E-0247
|
| Patent Term Extension Application for Omacor, U.S. Patent No. 5,698,594
|
| |
|
|
| 2005E-0254
|
| Patent Extension Application for ERBITUX, U.S. Patent No. 6,217,866
|
| |
|
|
| 2005E-0255
|
| Patent Extension Application for LUNESTA (exzoplclone), U.S. Patent No. 6,444,673
|
| |
|
|
| 2005E-0256
|
| Patent Extension Application for Ovidrel (choriogonadotropin alfa (recombinant human chorionic gonadotripin (r-HCG)), U.S. Patent No. 4,840,896
|
| |
|
|
| 2005H-0271
|
| Civil Money Penalty: TMJ Implants, Inc.
|
| |
|
|
| 2005P-0282
|
| Require Health Messages on Soft Drinks
|
| |
|
|
| 2005V-0172
|
| Laser Light Show
|
| |
|
|
| 2005V-0281
|
| Laser Light Show
|
| |
|
|
| 1977N-0318
|
| Penicillin & Tetracycline and all Combinations
|
| |
|
|
| ANS 1183
|
| HFC-20 to Mr. J. H. Bethards
|
| Vol #:
|
| 45
|
| |
|
|
| 1991V-0204
|
| Laser Light Show
|
| |
|
|
| EXP 4
|
| Mare-Bare, Inc./dba Stardust Hotel & Casino
|
| Vol #:
|
| 1
|
| |
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
| |
|
|
| C 7496
|
| T. Emory
|
| Vol #:
|
| 319
|
|
| |
|
| 2002E-0065
|
| Patent Term Application for Kineret No. 5,075,222
|
|
| | | | | | | | |
| |
|
|
| LET
4
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2002E-0344
|
| Patent Term Application for ATS Open Pivot Bileaf Valve 5,35
|
| |
|
|
| LET
3
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
| |
|
| 2003E-0033
|
| Patent Extension Application for DERMAGRAFT No. 4,963,489
|
| |
|
|
| LET
5
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2003E-0410
|
| Patent Term Restoration Application for Zubrin (tepoxalin), U.S. Patent No. 4,826,868
|
| |
|
|
| LET
3
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2003P-0176
|
| Follow-Up Approval of Therapeutic Protein Products
|
| |
|
|
| C
3
|
| Covington & Burling
|
| Vol #:
|
| 3
|
| |
|
|
| 2004E-0402
|
| Patent Extension for AVASTIN (bevacizumab), U.S. Patent No. 6,054,297
|
| |
|
|
| LET
2
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2004P-0171
|
| Standards for 'Similarity' or 'Sameness' of Biotechnology-Derived Products
|
| |
|
|
| C
7
|
| Covington & Burling
|
| Vol #:
|
| 3
|
| |
|
|
| 2004V-0537
|
| Projector for a Laser Light Show
|
| |
|
|
| VRA
1
|
| HFZ-200 to Tribal Existance Productions
|
| Vol #:
|
| 1
|
| |
|
|
| 2005D-0122
|
| Guidance for Industry on Exploratory IND Studies
|
| |
|
|
| C 10
|
| J. Coupal, PhD
|
| Vol #:
|
| 1
|
| |
|
|
| C
11
|
| Novartis Pharmaceuticals, Corp.
|
| Vol #:
|
| 1
|
| |
|
|
| C
12
|
| Genentech
|
| Vol #:
|
| 1
|
| |
|
|
| 2005E-0233
|
| Patent Extension for OMACOR (EPA ethyl ester and DHA ethyl ester), U.S. Patent No. 5,502,077
|
| |
|
|
| LET
2
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2005E-0234
|
| Patent Extension Application for Macugen (pegaptanib sodium), U.S. Patent No. 6,051,698
|
| |
|
|
| LET
2
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2005E-0235
|
| Patent Extension Application for VESIcare (solifenacin succinate), U.S. Patent No. 6,017,927
|
| |
|
|
| LET
2
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2005E-0236
|
| Patent Extension Application for MULTIHANCE (gadobenate dimeglumine), U.S. Patent No. 4,912,246
|
| |
|
|
| LET
2
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2005E-0238
|
| Patent Extension Application for TYSABRI (natalizumab), U.S. Patent No. 5,840,299
|
| |
|
|
| LET
2
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
| |
|
| 2005E-0239
|
| Patent Extension Application for PRIALT (ziconotide), U.S. Patent No. 5,364,842
|
| |
|
|
| LET
2
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2005E-0246
|
| Patent Extension Appliation for PRIALT (ziconotide), U.S. Patent No. 5,795,864
|
| |
|
|
| LET
2
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
| |
|
| 2005E-0247
|
| Patent Term Extension Application for Omacor, U.S. Patent No. 5,698,594
|
| |
|
|
| LET
2
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2005E-0254
|
| Patent Extension Application for ERBITUX, U.S. Patent No. 6,217,866
|
| |
|
|
| LET
2
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2005E-0255
|
| Patent Extension Application for LUNESTA (exzoplclone), U.S. Patent No. 6,444,673
|
| |
|
|
| LET
2
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2005E-0256
|
| Patent Extension Application for Ovidrel (choriogonadotropin alfa (recombinant human chorionic gonadotripin (r-HCG)), U.S. Patent No. 4,840,896
|
| |
|
|
| LET
2
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2005H-0271
|
| Civil Money Penalty: TMJ Implants, Inc.
|
| |
|
|
| LET
1
|
| GCF-1 to TMJ Implants, Inc, and Robert W. Christensen, and Maureen K Mooney
|
| Vol #:
|
| 1
|
| |
|
|
| 2005P-0282
|
| Require Health Messages on Soft Drinks
|
| |
|
|
| ACK
1
|
| HFA-305 to Center for Science in the Public Interest (CSPI)
|
| Vol #:
|
| 1
|
| |
|
|
| CP
1
|
| Center for Science in the Public Interest (CSPI)
|
| Vol #:
|
| 1
|
|
| |
|
| 2005V-0172
|
| Laser Light Show
|
| |
|
|
| VRA
1
|
| HFZ-200 to Connecticut Lasertainment dba Connecticut Lasers
|
| Vol #:
|
| 1
|
| |
|
|
| 2005V-0281
|
| Laser Light Show
|
| |
|
|
| ACK
1
|
| HFA-305 to C/J Media dba InterVision
|
| Vol #:
|
| 1
|
| |
|
|
| VAR
1
|
| C/J Media dba InterVision
|
| Vol #:
|
| 1
|
|
|
